COVID-19: Herd Immunity or Vaccination?
On Monday, Moderna Inc. said that the independent Data and Safety Monitoring Board (DSMB), appointed by the National Institutes of Health to study the Phase III trials of the vaccine against COVID-19, found it to be 94.5% effective. Dr. Satyajit Rath talks about the development of herd immunity and vaccines.
Newsclick Team

On Monday, Moderna Inc. said that the independent Data and Safety Monitoring Board (DSMB), appointed by the National Institutes of Health to study the Phase III trials of the vaccine against COVID-19, found it to be 94.5% effective. Dr. Satyajit Rath talks about the development of herd immunity and vaccines.

 

Get the latest reports & analysis with people's perspective on Protests, movements & deep analytical videos, discussions of the current affairs in your Telegram app. Subscribe to NewsClick's Telegram channel & get Real-Time updates on stories, as they get published on our website.